Expanding Clinical Partnerships Tasso is actively collaborating with major health systems, clinical research organizations, and medical centers across the US and internationally, creating opportunities to offer integrated at-home diagnostic solutions to a broad patient base.

Focus on Neuro and Disease Testing Recent integrations with Neurogen Biomarking and Parkinson's Foundation suggest a strategic emphasis on brain health and chronic disease management, opening potential sales avenues in both clinical and research settings targeting specialized diagnostics.

Innovative Blood Collection Tasso's patented needle-free, at-home blood testing technology addresses medical needs such as needle phobia and ease of sample collection, making it appealing for institutions seeking patient-friendly diagnostic solutions.

Rapid Market Adoption With recent partnerships supporting clinical research and patient prescreening, Tasso is positioned to expand its market share within the clinical trials sector and remote health monitoring, presenting growth opportunities for scalable diagnostic solutions.

Strong Funding and Growth Backed by $100 million in funding and generating substantial revenue, Tasso is financially well-positioned to invest in product expansion, sales outreach, and partnership development, offering a compelling value proposition for enterprise clients and strategic alliances.